AU0000120628
AU0000120628
DALRYMPLE STAPLED [DBI]
Loading chart...
Elevated Business & Solvency Risk
Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 35/100).
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
6/7 High
6 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.3x).
Beta (Market Relation)
0.26x
DefensiveVolatility (5Y p.a.)
22.4% p.a.
5-Year HorizonMax Drawdown (5Y)
-16.9%
5-Year HorizonSharpe Ratio
0.76
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Stable Long-Term Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | +26.9% |
| 3 Years | 22.0% | -16.9% | 1.06 | +26.6% |
| 5 Years | 22.4% | -16.9% | 0.76 | +19.5% |
| 10 Years | — | — | — | — |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 211%.
🔴 High valuation risk: Avg P/E of 79.4 (Elevated multiple compression risk)
Strong cyclicality: The business model is sensitive to economic downturns.